By Emeritus Professor Shane Darke

Journal articles

Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, 229, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112

Geddes L; Iversen J; Darke S; Dietze P; Maher L, 2021, 'Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia', International Journal of Drug Policy, 96, pp. 103245, http://dx.doi.org/10.1016/j.drugpo.2021.103245

Lappin JM; Darke S, 2021, 'Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review', Experimental Neurology, 343, pp. 113793, http://dx.doi.org/10.1016/j.expneurol.2021.113793

Campbell G; Darke S; Zahra E; Duflou J; Shand F; Lappin J, 2021, 'Trends and characteristics in barbiturate deaths Australia 2000-2019: a national retrospective study', Clinical Toxicology Philadelphia Pa, 59, pp. 224 - 230, http://dx.doi.org/10.1080/15563650.2020.1789653

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Darke S; Peacock A; Duflou J; Farrell M; Lappin J; Peacock A, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378

Hall W; Darke S; Humphreys K; Marsden J; Neale J; West R, 2020, 'Addiction's policy on publishing effectiveness studies of involuntary treatment of addiction and its variants', Addiction, 115, pp. 1795 - 1796, http://dx.doi.org/10.1111/add.14933

Campbell G; Darke S; Degenhardt L; Townsend H; Carter G; Draper B; Farrell M; Duflou J; Lappin J, 2020, 'Prevalence and Characteristics Associated with Chronic Noncancer Pain in Suicide Decedents: A National Study', Suicide and Life Threatening Behavior, 50, pp. 778 - 791, http://dx.doi.org/10.1111/sltb.12627

Marel C; Mills K; Visontay R; Wilson J; Darke S; Ross J; Slade T; Haber PS; Haasnoot K; Keaveny M; Tremonti C; Teesson M, 2020, 'Australian treatment outcome study: Protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2020-039226

Zahra E; Darke S; Degenhardt L; Campbell G, 2020, 'Rates, characteristics and manner of cannabis-related deaths in Australia 2000–2018', Drug and Alcohol Dependence, 212, http://dx.doi.org/10.1016/j.drugalcdep.2020.108028

Marsden J; Darke S; Hall W; Hickman M; Holmes J; Humphreys K; Neale J; Tucker J; West R, 2020, 'Mitigating and learning from the impact of COVID-19 infection on addictive disorders', Addiction, 115, pp. 1007 - 1010, http://dx.doi.org/10.1111/add.15080

Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2020, 'Characteristics and circumstances of synthetic cannabinoid-related death', Clinical Toxicology, 58, pp. 368 - 374, http://dx.doi.org/10.1080/15563650.2019.1647344

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2019, 'Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia', Drug and Alcohol Dependence, 204, http://dx.doi.org/10.1016/j.drugalcdep.2019.107556

Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729

Memedovic S; Slade T; Ross J; Darke S; Mills KL; Marel C; Burns L; Lynskey M; Teesson M, 2019, 'Rumination and problematic substance use among individuals with a long-term history of illicit drug use', Drug and Alcohol Dependence, 203, pp. 44 - 50, http://dx.doi.org/10.1016/j.drugalcdep.2019.05.028

Marel C; Mills KL; Slade T; Darke S; Ross J; Teesson M, 2019, 'Modelling Long-Term Joint Trajectories of Heroin Use and Treatment Utilisation: Findings from the Australian Treatment Outcome Study', Eclinicalmedicine, 14, pp. 71 - 79, http://dx.doi.org/10.1016/j.eclinm.2019.07.013

Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Psychostimulant Use and Fatal Stroke in Young Adults', Journal of Forensic Sciences, 64, pp. 1421 - 1426, http://dx.doi.org/10.1111/1556-4029.14056

Lappin JM; Darke S, 2019, 'Methamphetamine: An emerging cause of intracerebral hemorrhage in young people', Neurology, 93, pp. 13 - 14, http://dx.doi.org/10.1212/WNL.0000000000007667

Darke S; Duflou J; Kaye S; Farrell M; Lappin J, 2019, 'Body mass index and fatal stroke in young adults: A national study', Journal of Forensic and Legal Medicine, 63, pp. 1 - 6, http://dx.doi.org/10.1016/j.jflm.2019.02.003

Darke S, 2019, 'Commentary on Stam et al. (2019): Drugs, death and statistics', Addiction, 114, pp. 513 - 514, http://dx.doi.org/10.1111/add.14520

Darke S; Kaye S; Duflou J; Lappin J, 2019, 'Completed Suicide Among Methamphetamine Users: A National Study', Suicide and Life Threatening Behavior, 49, pp. 328 - 337, http://dx.doi.org/10.1111/sltb.12442

Darke S, 2019, 'Clinical issues: substance use disorders and the body', Addiction, 114, pp. 1526, http://dx.doi.org/10.1111/add.14639

Darke S; Farrell M, 2018, 'Burroughs’ ‘Letter from a master addict to dangerous drugs’: a forgotten classic', Addiction, 113, pp. 2305 - 2308, http://dx.doi.org/10.1111/add.14391

Bleeker A; Crowther MS; Darke S; Lintzeris N; McGregor IS, 2018, 'David J. Allsop (7.12.1974-2013.8.2018)', Drug and alcohol review, 37, pp. 922 - 923, http://dx.doi.org/10.1111/dar.12865

West R; Marsden J; Humphreys K; Darke S, 2018, 'A revised checklist for writing up research reports', Addiction, 113, pp. 1567 - 1570, http://dx.doi.org/10.1111/add.14269

Darke S; Duflou J; Lappin J; Kaye S, 2018, 'Clinical and Autopsy Characteristics of Fatal Methamphetamine Toxicity in Australia', Journal of Forensic Sciences, 63, pp. 1466 - 1471, http://dx.doi.org/10.1111/1556-4029.13710

Lappin JM; Darke S; Farrell M, 2018, 'Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications', Drug and Alcohol Dependence, 187, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2018.02.032

Mills KL; Marel C; Darke S; Ross J; Slade T; Teesson M, 2018, 'The long-term impact of post traumatic stress disorder on recovery from heroin dependence', Journal of Substance Abuse Treatment, 89, pp. 60 - 66, http://dx.doi.org/10.1016/j.jsat.2018.04.001

Darke S; Lappin J; Kaye S; Duflou J, 2018, 'Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National Study', Journal of Forensic Sciences, 63, pp. 735 - 739, http://dx.doi.org/10.1111/1556-4029.13620

Wiessing L; Ferri M; Darke S; Simon R; Griffiths P, 2018, 'Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies', Drug and Alcohol Review, 37, pp. S323 - S338, http://dx.doi.org/10.1111/dar.12608

Larance B; Gisev N; Cama E; Nelson EC; Darke S; Larney S; Degenhardt L, 2018, 'Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence', Drug and Alcohol Dependence

Humphreys K; Darke S; Marsden J; West R, 2018, 'Extending Addiction's conflict of interest policy to cover the emerging cannabis industry', Addiction Abingdon England, 113, pp. 205, http://dx.doi.org/10.1111/add.14098

Lappin JM; Darke S; Duflou J; Kaye S; Farrell M, 2018, 'Fatal stroke in pregnancy and the puerperium: Case series', Stroke, 49, pp. 3050 - 3053, http://dx.doi.org/10.1161/STROKEAHA.118.023274

Darke S; Kaye S; Duflou J, 2017, 'Methamphetamine-related death is an under-addressed public health problem', Addiction, 112, pp. 2204 - 2205, http://dx.doi.org/10.1111/add.14035

Darke S; Kaye S; Duflou J, 2017, 'Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study', Addiction, 112, pp. 2191 - 2201, http://dx.doi.org/10.1111/add.13897

Darke S; Duflou J; Kaye S, 2017, 'Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study', Drug and Alcohol Dependence, 179, pp. 174 - 179, http://dx.doi.org/10.1016/j.drugalcdep.2017.07.001

Lappin JM; Darke S; Farrell M, 2017, 'Stroke and methamphetamine use in young adults: a review', Journal of Neurology Neuropsychiatry and Psychiatry, 88, pp. 1079 - 1091, http://dx.doi.org/10.1136/jnnp-2017-316071

Roxburgh A; Darke ; Salmon ; Dobbins ; Jauncey , 2017, 'Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre', Drug and Alcohol Dependence, 176, pp. 126 - 132, http://dx.doi.org/10.1016/j.drugalcdep.2017.02.027

Teesson M; Marel C; Darke S; Ross J; Slade T; Burns L; Lynskey M; Memedovic S; White J; Mills KL, 2017, 'Trajectories of heroin use: 10–11-year findings from the Australian Treatment Outcome Study', Addiction, 112, pp. 1056 - 1068, http://dx.doi.org/10.1111/add.13747

Darke S; Torok M; Ross J, 2017, 'Developmental trajectories to heroin dependence: Theoretical and clinical issues', Journal of Applied Social Psychology, 47, pp. 165 - 171, http://dx.doi.org/10.1111/jasp.12434

Darke S; Larney S; Farrell M, 2017, 'Yes, people can die from opiate withdrawal', Addiction, 112, pp. 199 - 200, http://dx.doi.org/10.1111/add.13512

Darke S; Duflou J, 2017, 'Characteristics, circumstances and pathology of sudden or unnatural deaths of cases with evidence of pathological hoarding', Journal of Forensic and Legal Medicine, 45, pp. 36 - 40, http://dx.doi.org/10.1016/j.jflm.2016.11.004

Darke S; Duflou J, 2016, 'Response to Ruan and colleagues concerning ‘The toxicology of heroin-related death: estimating survival times’', Addiction, 111, pp. 2262, http://dx.doi.org/10.1111/add.13587

Darke S, 2016, 'Addiction Classics', Addiction, 111, pp. 1899, http://dx.doi.org/10.1111/add.13530

Darke S, 2016, 'Heroin overdose', Addiction Abingdon England, 111, pp. 2060 - 2063, http://dx.doi.org/10.1111/add.13516

Torok M; Darke S; Shand F; Kaye S, 2016, 'Investigating heterogeneity in violent offending liability among injection drug users from a developmental perspective', Addictive Behaviors, 60, pp. 165 - 170, http://dx.doi.org/10.1016/j.addbeh.2016.04.013

Darke S; Duflou J, 2016, 'The toxicology of heroin-related death: estimating survival times', Addiction Abingdon England, 111, pp. 1607 - 1613, http://dx.doi.org/10.1111/add.13429

Darke S; Slade T; Ross J; Marel C; Mills KL; Tessson M, 2016, 'Patterns and correlates of injecting among heroin users: A 11-year follow-up of the Australian treatment outcome study cohort', Addictive Disorders and their Treatment, 15, pp. 111 - 119, http://dx.doi.org/10.1097/ADT.0000000000000082

Darke S; Farrell M, 2016, 'Commentary on Singh et al. (2016): Still searching for the answer', Addiction Abingdon England, 111, pp. 1347, http://dx.doi.org/10.1111/add.13369

Back to profile page